(Q33775526)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

title

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Adina Turcu-Ştiolică

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Guenka Petrova

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1

Paweł Kawalec

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Ewa Stawowczyk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jana Skoupa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Maria Dimitrova

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Zinta Rugaja

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Agnes Männik

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Andras Harsanyi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Pero Draganic

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

publication date

8 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

Frontiers in Pharmacology

23 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

page(s)

288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

Key drivers for market penetration of biosimilars in Europe.

23 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5463127

Relating Health Technology Assessment recommendations and reimbursement decisions in Poland in years 2012-2014, a retrospective analysis.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5463127

Pharmaceutical regulation in 15 European countries review

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5463127

Core Concepts: Biosimilars

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5463127

A budget impact model for biosimilar infliximab in Crohn's disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia

4 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.3389%2FFPHAR.2017.00288

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28642700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Experiences with price competition of biosimilar drugs in Hungary]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28642700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Budget Impact Analysis Of Biosimilar Infliximab For The Treatment Of Crohn's Disease In Six Central Eastern European Countries

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28642700

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FPHAR.2017.00288

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28642700%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference